Antiplatelet de-escalation after complex PCI: when and how?

Anchorperson: P. Capranzano
Spokesperson: M. Valgimigli
SHOW MORE

Learning Objectives

  • To learn how to de-escalate by "switch"
  • To identify good candidates to de-escalation by "dose reduction"
  • To decide if de-escalation by discontinuation should occur by stopping either aspirin or not, and when

Presentations available when logged in:

  • Session objectives
  • Case presentation 1 - Complex PCI and CCS: an ideal case for short DAPT
  • Case 1 conclusion
  • Case presentation 1- Complex PCI and ACS: an ideal case for P2Y12 inhibitor de-escalation
  • Case 2 conclusion
  • DAPT de-escalation strategies: which approach for which patients